C.R. Bard, Inc. (NYSE:BCR)

CAPS Rating: 4 out of 5

The Company is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.

Recs

0
Player Avatar SnowBawl (< 20) Submitted: 12/19/2011 9:07:13 AM : Outperform Start Price: $85.89 BCR Score: +8.08

Elfenbein '12 (1 of 4).

Report this Post Reply

Featured Broker Partners


Advertisement